Neoplasms: all 9,616 studies

Page 28 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or MutationsTerminatedNCT04161391Phase 1/2Results posted
• A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid TumorsTerminatedNCT04158583Phase 1Results posted
• A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsTerminatedNCT04157517Phase 1/2Results posted
• A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerCompletedNCT04148937Phase 1Results posted
• A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)CompletedNCT04147234Phase 1Results posted
• A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal CancerCompletedNCT04137289Phase 1Results posted
• A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid TumorsCompletedNCT04116710Phase 1Results posted
• Precision Medicine for Patients With Identified Actionable MutationsTerminatedNCT04111107Phase 2Results posted
• Phase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsTerminatedNCT04106492Phase 1/2Results posted
• Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)CompletedNCT04098068Phase 2Results posted
• Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaCompletedNCT04089488Results posted
• Phase 1/2 Study of OBI-999 in Patients With Advanced Solid TumorsTerminatedNCT04084366Phase 1/2Results posted
• eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer SurvivorsTerminatedNCT04081298Not applicableResults posted
• FPT155 in Patients With Advanced Solid TumorsTerminatedNCT04074759Phase 1Results posted
• Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyTerminatedNCT04066894Phase 2Results posted
• Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer PatientsCompletedNCT04055948Not applicableResults posted
• Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid TumorsTerminatedNCT04049617Phase 1Results posted
• Mindfulness Based Smoking Cessation Among Cancer SurvivorsTerminatedNCT04038255Phase 4Results posted
• Functional Exercise and Nutrition Education Program for Older AdultsCompletedNCT04037436Not applicableResults posted
• Symptom Management for YA Cancer SurvivorsCompletedNCT04035447Not applicableResults posted
• Safety and Efficacy Study of IMSA101 in Refractory MalignanciesCompletedNCT04020185Phase 1/2Results posted
• Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)TerminatedNCT04003623Phase 2Results posted
• Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic SurgeriesTerminatedNCT04000581Not applicableResults posted
• PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid TumorsTerminatedNCT03993379Phase 2Results posted
• Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerCompletedNCT03993353Phase 2Results posted
• Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCCompletedNCT03989115Phase 1/2Results posted
• Broadening the Reach, Impact, and Delivery of Genetic ServicesCompletedNCT03985852Not applicableResults posted
• Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.CompletedNCT03980925Phase 2Results posted
• A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced CancerCompletedNCT03972150Phase 1Results posted
• Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials (SURROGATE-ICI)CompletedNCT03963518Results posted
• Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer OriginTerminatedNCT03960021Not applicableResults posted
• Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid TumorsTerminatedNCT03954704Phase 1Results posted
• A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)TerminatedNCT03948763Phase 1Results posted
• Split-Dose R-CHOP for Older Adults With DLBCLActive, not recruitingNCT03943901Phase 2Results posted
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic ConditionsCompletedNCT03938324Not applicableResults posted
• Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell CarcinomaActive, not recruitingNCT03937219Phase 3Results posted
• A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerTerminatedNCT03936959Phase 1Results posted
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsCompletedNCT03935282Not applicableResults posted
• CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder CancerActive, not recruitingNCT03933826Results posted
• A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine StudiesTerminatedNCT03926143Phase 2Results posted
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung CancerCompletedNCT03915951Phase 2Results posted
• Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap MonitoringTerminatedNCT03915717Results posted
• A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.CompletedNCT03907969Phase 1/2Results posted
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsActive, not recruitingNCT03899792Phase 1/2Results posted
• Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid TumoursTerminatedNCT03894540Phase 1Results posted
• TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced CancersCompletedNCT03884556Phase 1Results posted
• Tailored Home-Based Exercise Program for Multiple Chronic ConditionsCompletedNCT03874754Not applicableResults posted
• Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With CancerCompletedNCT03857620Not applicableResults posted
• A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid TumorsTerminatedNCT03854227Phase 1Results posted
• A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid TumorsTerminatedNCT03843359Phase 1Results posted
• Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With CancerTerminatedNCT03839940Phase 3Results posted
• Durvalumab and Tremelimumab for Pediatric MalignanciesActive, not recruitingNCT03837899Phase 1/2Results posted
• Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)TerminatedNCT03834220Phase 2Results posted
• Patient-caregiver Communication Intervention for Prognostic UnderstandingCompletedNCT03833817Not applicableResults posted
• Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001)TerminatedNCT03833427Phase 1Results posted
• Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness TrialCompletedNCT03824158Not applicableResults posted
• Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate CancerCompletedNCT03822845Phase 2/3Results posted
• Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLCCompletedNCT03822351Phase 2Results posted
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsCompletedNCT03814005Phase 1Results posted
• Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology PracticesCompletedNCT03808818Not applicableResults posted
• IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell CarcinomaCompletedNCT03795610Phase 2Results posted
• A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial CancerCompletedNCT03785925Phase 2Results posted
• Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)TerminatedNCT03769467Phase 1/2Results posted
• A Stress Management and Resiliency Program for Adolescent and Young Adult SurvivorsActive, not recruitingNCT03768336Not applicableResults posted
• A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell TumorsCompletedNCT03760081Phase 2Results posted
• Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer TherapyActive, not recruitingNCT03755791Phase 3Results posted
• Trial of Pembrolizumab in Cancer of Unknown PrimaryCompletedNCT03752333Phase 2Results posted
• Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical TumorsTerminatedNCT03752203Not applicableResults posted
• A Study of LY3415244 in Participants With Advanced Solid TumorsTerminatedNCT03752177Phase 1Results posted
• Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland CancersCompletedNCT03749460Phase 1/2Results posted
• Project to Improve Communication About Serious Illness - Pilot StudyCompletedNCT03746392Not applicableResults posted
• Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)CompletedNCT03745989Phase 1Results posted
• A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)CompletedNCT03744676Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 2CompletedNCT03743064Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1CompletedNCT03743051Phase 3Results posted
• Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)TerminatedNCT03739138Phase 1Results posted
• Xpede Clinical StudyCompletedNCT03730207Not applicableResults posted
• Hepatic Impairment Study for Lorlatinib in Cancer PatientsTerminatedNCT03726333Phase 1Results posted
• Study of Avelumab-M3814 CombinationsCompletedNCT03724890Phase 1Results posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic MalignanciesTerminatedNCT03717480Phase 2Results posted
• A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid TumorsTerminatedNCT03717415Phase 1/2Results posted
• Compassionate Use Study of Tenalisib (RP6530)CompletedNCT03711604Phase 1/2Results posted
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsCompletedNCT03709680Phase 2Results posted
• Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic CancerCompletedNCT03697564Phase 2Results posted
• Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)CompletedNCT03694171Results posted
• Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisCompletedNCT03691493Phase 2Results posted
• REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent GliomaTerminatedNCT03690869Phase 1/2Results posted
• PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
• A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationCompletedNCT03684811Phase 1/2Results posted
• Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological SurgeryCompletedNCT03681405Not applicableResults posted
• Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell TransplantationCompletedNCT03680092Phase 2Results posted
• Assessing Patient-reported & Patient-related Outcomes in Randomized Cancer Trials for Older AdultsCompletedNCT03676218Results posted
• Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)Active, not recruitingNCT03676010Results posted
• The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced CancerCompletedNCT03668223Not applicableResults posted
• A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)CompletedNCT03668119Phase 2Results posted
• A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid TumorsCompletedNCT03666143Phase 1Results posted
• Talimogene Laherparepvec for the Treatment of Peritoneal Surface MalignanciesCompletedNCT03663712Phase 1Results posted
• A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).Active, not recruitingNCT03653507Phase 3Results posted
• Nivolumab With or Without Ipilimumab in Advanced Metastatic CancerCompletedNCT03651271Phase 2Results posted

← Neoplasms overview